Jefferies Upgrades BioCryst Pharma (BCRX) to Buy

August 4, 2023 7:12 AM EDT Send to a Friend
Jefferies analyst Maury Raycroft upgraded BioCryst Pharma (NASDAQ: BCRX) from Hold ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to Premium below (Free Trial) LEARN MORE

Member Login